Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PRTA Prothena > Detailed Quotes

PRTA Prothena

59.470
+1.470+2.53%
Close 09/29 16:00 ET
59.4700.0000.00%
Pre Mkt Price 09/30 04:00 ET
High
61.200
Open
56.250
Turnover
232.53M
Low
55.520
Pre Close
58.000
Volume
3.95M
Market Cap
2.79B
P/E(TTM)
Loss
52wk High
74.320
Shares
46.92M
P/E(Static)
43.09
52wk Low
21.060
Float Cap
1.26B
Bid/Ask %
0.00%
Historical High
79.749
Shs Float
21.20M
Volume Ratio
1.49
Historical Low
5.640
Dividend TTM
--
Div Yield TTM
--
P/B
6.85
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
18.63%
Amplitude
9.79%
Avg Price
58.884
Lot Size
1
Float Cap
1.26B
Bid/Ask %
0.00%
Historical High
79.749
Shs Float
21.20M
Volume Ratio
1.49
Historical Low
5.640
Dividend TTM
--
P/B
6.85
Dividend LFY
--
Turnover Ratio
18.63%
Amplitude
9.79%
Avg Price
58.884
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firm抯 clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer抯 disease, Parkinson抯 disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
CEO: Dr. Gene G. Kinney
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...